Skip to main content
. Author manuscript; available in PMC: 2016 Feb 13.
Published in final edited form as: Oncogene. 2014 Nov 10;34(33):4311–4319. doi: 10.1038/onc.2014.360

Figure 4. SRPK1-KD reduces tumour growth in PC3 xenografts in nude mice.

Figure 4

A. Quantitations of the tumour volumes in control and SRPK1-KD mice. B. Examples of tumour growth in both mice groups (tumours outlined in black). C. Examples of microscopic fields of control and SRPK1-KD tumours stained for CD31. Arrows indicate blood vessels. D. Quantitation of microvessel density in control and SRPK1-KD tumours. E. Western blot analysis of SRPK1 and VEGF in duplicate tumours from control and SRPK1-KD groups

HHS Vulnerability Disclosure